Are COVID-19 vaccine boosters needed? The science behind boosters

RM Burckhardt, JJ Dennehy, LLM Poon, LJ Saif… - Journal of …, 2022 - Am Soc Microbiol
Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants
has led to increases in breakthrough infections, prompting consideration for vaccine booster …

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

RK Suryawanshi, IP Chen, T Ma, AM Syed, N Brazer… - Nature, 2022 - nature.com
Abstract SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although
individuals infected with Delta are at risk of developing severe lung disease, infection with …

Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors

L Pérez-Alós, JJA Armenteros, JR Madsen… - Nature …, 2022 - nature.com
SARS-CoV-2 vaccines are crucial in controlling COVID-19, but knowledge of which factors
determine waning immunity is limited. We examined antibody levels and T-cell gamma …

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

K Yin, MJ Peluso, X Luo, R Thomas, MG Shin… - Nature …, 2024 - nature.com
Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used …

COVID-19 vaccine–related myocardial and pericardial inflammation

M Furqan, S Chawla, M Majid, S Mazumdar… - Current Cardiology …, 2022 - Springer
Abstract Purpose of Review To review myocarditis and pericarditis developing after COVID-
19 vaccinations and identify the management strategies. Recent Findings COVID-19 mRNA …

ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients

A Picchianti-Diamanti, A Aiello, B Laganà… - Frontiers in …, 2021 - frontiersin.org
Objective To assess in rheumatoid arthritis (RA) patients, treated with different
immunosuppressive therapies, the induction of SARS-CoV-2-specific immune response …

COVID-19 delta variant: perceptions, worries, and vaccine-booster acceptability among healthcare workers

K Alhasan, F Aljamaan, MH Temsah, F Alshahrani… - Healthcare, 2021 - mdpi.com
Background: As the COVID-19 Delta variant has spread across the globe, healthcare
workers'(HCWs) knowledge, worries, and vaccine booster acceptance should be assessed …

SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron

A Mazzoni, A Vanni, M Spinicci, M Capone… - Frontiers in …, 2022 - frontiersin.org
Although accumulating data have investigated the effect of SARS-CoV-2 mutations on
antibody neutralizing activity, less is known about T cell immunity. In this work, we found that …

Oral delivery of mRNA vaccine by plant-derived extracellular vesicle carriers

MAC Pomatto, C Gai, F Negro, L Massari… - Cells, 2023 - mdpi.com
mRNA-based vaccines were effective in contrasting SARS-CoV-2 infection. However, they
presented several limitations of storage and supply chain, and their parenteral …

Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines

P Kaplonek, Y Deng, JSL Lee, HJ Zar, D Zavadska… - Cell Reports …, 2023 - cell.com
Despite the successes of current coronavirus disease 2019 (COVID-19) vaccines, waning
immunity, the emergence of variants of concern, and breakthrough infections among …